Active	Status	Sponsor type	Region	Phase	Filter
2 Active 4 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Cucchiara, Salvatore
CDGEMM, NCT02061306: Celiac Disease Genomic Environmental Microbiome and Metabolomic Study	Recruiting	N/A	500	Europe, US		Massachusetts General Hospital, University of Roma La Sapienza, Università Politecnica delle Marche	Celiac Disease	12/24	12/24
Somma, Salvatore Di
ADESTE, NCT04252937: Adrecizumab Dose Escalation Safety and Tolerability Evaluation	Recruiting	2	30	RoW	Adrecizumab, HAM8101 (Adrecizumab)	GREAT Network Italy	Acute Heart Failure	12/21	03/22